Nektar Therapeutics : NKTR

All Nektar Therapeutics Articles

59 Articles

Jon C. Ogg | Nov 9, 2017 at 9:00 AM EST

Top Analyst Upgrades and Downgrades: Biogen, Cabot Oil & Gas, CenturyLink, NetApp, Square, T-Mobile, Wix.com and More

The top analyst upgrades, downgrades and other research calls from Thursday include Biogen, Cabot Oil & Gas, CenturyLink, NetApp, Square,…

Jon C. Ogg | Nov 7, 2017 at 9:05 AM EST

Top Analyst Upgrades and Downgrades: Altice USA, CVS Health, Exxon, Lowe’s, T-Mobile, Sprint, Under Armour and More

The top analyst upgrades, downgrades and other research calls from Tuesday include Altice USA, CVS Health, Exxon, Lowe's, T-Mobile, Sprint…

Jon C. Ogg | Aug 7, 2017 at 9:10 AM EDT

Top Analyst Upgrades and Downgrades: BlackBerry, BP, Camping World, Deere, GrubHub, KLA-Tencor, Teva, Zions and More

The top analyst upgrades, downgrades and other research calls from Monday include BlackBerry, BP, Camping World, Deere, GrubHub, KLA-Tencor, Teva…

Jon C. Ogg | Apr 24, 2017 at 8:35 AM EDT

Top Analyst Upgrades and Downgrades: AK Steel, Amazon, AngloGold Ashanti, Bank of America, GE, Disney, Xilinx and More

The top analyst upgrades, downgrades and initiations seen on Monday include AK Steel, Amazon.com, AngloGold Ashanti, Bank of America, General…

Jon C. Ogg | Mar 21, 2017 at 8:40 AM EDT

Top Analyst Upgrades and Downgrades: Carnival, Facebook, Freeport-McMoRan, Motorola Solutions, Procter & Gamble and Many More

The top analyst upgrades, downgrades and initiations seen on Tuesday include Carnival, Facebook, Freeport-McMoRan, Motorola Solutions and Procter & Gamble.

Chris Lange | Mar 20, 2017 at 10:55 AM EDT

Monday’s Top Biopharma Movers

Esperion Therapeutics and a few other biopharma stocks made massive runs on Monday morning.

Jon C. Ogg | Jan 6, 2017 at 9:12 AM EST

Top Analyst Upgrades and Downgrades: Cognizant Tech, Etsy, GoPro, Illumina, Shake Shack, Travelers and More

The top analyst upgrades, downgrades and initiations seen on Friday, January 6, include Cognizant Technology Solutions, Etsy, GoPro, Illumina, Shake…

Lee Jackson | Oct 30, 2016 at 10:10 AM EDT

Massive Energy Trade Highlights Insider Blue Chip Buying: Kinder Morgan, AT&T, Kimberly-Clark, IBM, Johnson & Johnson and More

With the busiest earnings week behind us, it appears some of the restriction windows at major U.S. corporations are starting…

Chris Lange | Oct 19, 2016 at 11:25 AM EDT

Nektar Slides on Secondary Offering Pricing

Nektar Therapeutics plans to price 13 million shares at $13.50 for a secondary offering valued up to almost $202 million.

Jon C. Ogg | Feb 8, 2016 at 8:55 AM EST

Top Analyst Upgrades and Downgrades: Athenahealth, Baker Hughes, Cisco, LinkedIn, Orbital-ATK, Tableau and Many More

The top analyst upgrades, downgrades and initiations seen on Monday, February 8 include Athenahealth, Baker Hughes, Cisco, LinkedIn, Orbital-ATK and…

Lee Jackson | Jul 17, 2015 at 9:05 AM EDT

Huge Biotech Index Rebalance Means Massive Buy Orders for 5 Stocks

The analysts at Cowen have calculated the buys and sells in the NYSE Arca Biotechnology Index based on the holdings…

Chris Lange | Apr 18, 2015 at 9:40 AM EDT

5 Big Biotechs Not Keeping Up at All With Hot Biotech Sector in 2015

The health care sector and biotech in particular have been on fire so far in 2015, but some biotech stocks…

Lee Jackson | Apr 17, 2015 at 8:20 AM EDT

Huge Biotech Index Rebalance Means Massive Buy Orders for These 4 Stocks

On the close Friday, the NYSE Arca Biotechnology Index is set for a rebalance. These four stocks that could see…

Trey Thoelcke | Apr 22, 2014 at 9:50 AM EDT

Jefferies Initiates Coverage on Specialty Pharmaceutical Takeover Candidates

The specialty pharmaceutical sector is exploding with news of takeovers, exchanges and possible mergers. Here are some of the top…

Jon C. Ogg | Jan 31, 2014 at 8:55 AM EST

Russell 2000 Rebalance May Bring Huge Buying in Key Stocks

The Quantitative Strategies team at Jefferies closely monitors the index changes. 24/7 Wall St. screened the Jefferies list of stocks…

1 2 3 4

Nektar Therapeutics : NKTR

All Nektar Therapeutics Articles

Top Analyst Upgrades and Downgrades: Biogen, Cabot Oil & Gas, CenturyLink, NetApp, Square, T-Mobile, Wix.com and More

Top Analyst Upgrades and Downgrades: Altice USA, CVS Health, Exxon, Lowe’s, T-Mobile, Sprint, Under Armour and More

Top Analyst Upgrades and Downgrades: BlackBerry, BP, Camping World, Deere, GrubHub, KLA-Tencor, Teva, Zions and More

Top Analyst Upgrades and Downgrades: AK Steel, Amazon, AngloGold Ashanti, Bank of America, GE, Disney, Xilinx and More

Top Analyst Upgrades and Downgrades: Carnival, Facebook, Freeport-McMoRan, Motorola Solutions, Procter & Gamble and Many More

Monday’s Top Biopharma Movers

Top Analyst Upgrades and Downgrades: Cognizant Tech, Etsy, GoPro, Illumina, Shake Shack, Travelers and More

Massive Energy Trade Highlights Insider Blue Chip Buying: Kinder Morgan, AT&T, Kimberly-Clark, IBM, Johnson & Johnson and More

Nektar Slides on Secondary Offering Pricing

Top Analyst Upgrades and Downgrades: Athenahealth, Baker Hughes, Cisco, LinkedIn, Orbital-ATK, Tableau and Many More

Huge Biotech Index Rebalance Means Massive Buy Orders for 5 Stocks

5 Big Biotechs Not Keeping Up at All With Hot Biotech Sector in 2015

Huge Biotech Index Rebalance Means Massive Buy Orders for These 4 Stocks

Jefferies Initiates Coverage on Specialty Pharmaceutical Takeover Candidates

Russell 2000 Rebalance May Bring Huge Buying in Key Stocks

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

SoFi Stock Could Jump 26% as Market Overreacts to One Soft Segment

52% of Americans Are Building Wealth While Ignoring Their Greatest Risk

3 Reasons Retirees Should Not Enroll in Medicare Advantage for 2026

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

Nektar Therapeutics : NKTR

All Nektar Therapeutics Articles

Top Analyst Upgrades and Downgrades: Biogen, Cabot Oil & Gas, CenturyLink, NetApp, Square, T-Mobile, Wix.com and More

Top Analyst Upgrades and Downgrades: Altice USA, CVS Health, Exxon, Lowe’s, T-Mobile, Sprint, Under Armour and More

Top Analyst Upgrades and Downgrades: BlackBerry, BP, Camping World, Deere, GrubHub, KLA-Tencor, Teva, Zions and More

Top Analyst Upgrades and Downgrades: AK Steel, Amazon, AngloGold Ashanti, Bank of America, GE, Disney, Xilinx and More

Top Analyst Upgrades and Downgrades: Carnival, Facebook, Freeport-McMoRan, Motorola Solutions, Procter & Gamble and Many More

Monday’s Top Biopharma Movers

Top Analyst Upgrades and Downgrades: Cognizant Tech, Etsy, GoPro, Illumina, Shake Shack, Travelers and More

Massive Energy Trade Highlights Insider Blue Chip Buying: Kinder Morgan, AT&T, Kimberly-Clark, IBM, Johnson & Johnson and More

Nektar Slides on Secondary Offering Pricing

Top Analyst Upgrades and Downgrades: Athenahealth, Baker Hughes, Cisco, LinkedIn, Orbital-ATK, Tableau and Many More

Huge Biotech Index Rebalance Means Massive Buy Orders for 5 Stocks

5 Big Biotechs Not Keeping Up at All With Hot Biotech Sector in 2015

Huge Biotech Index Rebalance Means Massive Buy Orders for These 4 Stocks

Jefferies Initiates Coverage on Specialty Pharmaceutical Takeover Candidates

Russell 2000 Rebalance May Bring Huge Buying in Key Stocks

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

SoFi Stock Could Jump 26% as Market Overreacts to One Soft Segment

Featured Reads

52% of Americans Are Building Wealth While Ignoring Their Greatest Risk

3 Reasons Retirees Should Not Enroll in Medicare Advantage for 2026